Cover Image

Bruceine D Identified as a Drug Candidate against Breast Cancer by a Novel Drug Selection Pipeline and Cell Viability Assay

The multi-target effects of natural products allow us to fight complex diseases like cancer on multiple fronts. Unlike docking techniques, network-based approaches such as genome-scale metabolic modelling can capture multi-target effects. However, the incompleteness of natural product target informa...

Full description

Saved in:

Bibliographic Details
Main Authors:	Claudia Cipriani (Author), Maria Pires Pacheco (Author), Ali Kishk (Author), Maryem Wachich (Author), Daniel Abankwa (Author), Elisabeth Schaffner-Reckinger (Author), Thomas Sauter (Author)
Format:	Book
Published:	MDPI AG, 2022-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A brief overview of antitumoral actions of bruceine D
by: Zi Wayne Sin, et al.
Published: (2020)

Development of a High-throughput Agar Colony Formation Assay to Identify Drug Candidates against Medulloblastoma
by: Mohammed Sedeeq, et al.
Published: (2020)

Computational drug discovery pipelines identify NAMPT as a therapeutic target in neuroendocrine prostate cancer
by: Weijie Zhang, et al.
Published: (2024)

A Systematic Comparison Identifies an ATP-Based Viability Assay as Most Suitable Read-Out for Drug Screening in Glioma Stem-Like Cells
by: A. Kleijn, et al.
Published: (2016)

A Review of Current and Pipeline Drugs for Treatment of Melanoma
by: Nicole Natarelli, et al.
Published: (2024)

Antibody-Drug Conjugates in the Pipeline for Treatment of Melanoma: Target and Pharmacokinetic Considerations
by: Ina Lami, et al.
Published: (2024)

Huntington's Disease Drug Development: A Phase 3 Pipeline Analysis
by: Hannah J. Van de Roovaart, et al.
Published: (2023)

An Integrated Deep Learning and Molecular Dynamics Simulation-Based Screening Pipeline Identifies Inhibitors of a New Cancer Drug Target TIPE2
by: Haiping Zhang, et al.
Published: (2021)

Drugs and Drug Candidates: Year in Review
by: Jean Jacques Vanden Eynde
Published: (2024)

Identifying candidate drugs based on transcriptional landscape associated with triple-negative breast cancer
by: Yuqin Lin, et al.
Published: (2023)

Zebrafish drug screening identifies candidate therapies for neuroprotection after spontaneous intracerebral haemorrhage
by: Siobhan Crilly, et al.
Published: (2022)

Considerations and Pitfalls in Selecting the Drug Vehicles for Evaluation of New Drug Candidates: Focus on in vivo Pharmaco-Toxicological Assays Based on the Rotarod Performance Test
by: Mariana Matias, et al.
Published: (2018)

The Pathologist Pipeline
by: Wesley Y. Naritoku MD, PhD, et al.
Published: (2016)

Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy
by: Christian K. Hirt, et al.
Published: (2022)

Bruceine D inhibits HIF-1α-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT/β-catenin interaction
by: Rui Huang, et al.
Published: (2021)

Bruceine a exerts antitumor effect against colon cancer by accumulating ROS and suppressing PI3K/Akt pathway
by: Chaozheng Zhang, et al.
Published: (2023)

A simple method to measure cell viability in proliferation and cytotoxicity assays
by: Ricardo Carneiro Borra, et al.
Published: (2009)

Drug Candidates for Autoimmune Diseases
by: Sabrina Saurin, et al.
Published: (2022)

Monitoring Adverse Drug Events in Web Forums: Evaluation of a Pipeline and Use Case Study
by: Pierre Karapetiantz, et al.
Published: (2024)

Improving the Drug Development Pipeline for Mycobacteria: Modelling Antibiotic Exposure in the Hollow Fibre Infection Model
by: Arundhati Maitra, et al.
Published: (2021)

Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline
by: Carles Cornet, et al.
Published: (2018)

A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus
by: Cécile Voisset, et al.
Published: (2014)

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
by: Norihiro Sakai, et al.
Published: (2023)

Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease
by: Denis N. Prada Gori, et al.
Published: (2023)

Molecular assays for determining Mycobacterium leprae viability in tissues of experimentally infected mice.
by: Grace L Davis, et al.
Published: (2013)

Pipeline Engineering Design, Failure, and Management
Published: (2023)

Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery.
by: Lorna M MacLean, et al.
Published: (2018)

Strategies for the Development of Glycomimetic Drug Candidates
by: Rachel Hevey
Published: (2019)

A target repurposing approach identifies N-myristoyltransferase as a new candidate drug target in filarial nematodes.
by: Brendan D Galvin, et al.
Published: (2014)

Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease
by: Philip W. Brownjohn, et al.
Published: (2024)

Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma.
by: Wilson Lim, et al.
Published: (2022)

Identifying novel candidate compounds for therapeutic strategies in retinopathy of prematurity via computational drug-gene association analysis
by: Edward F. Xie, et al.
Published: (2023)

Quantitative evaluation of human sperm viability using MTT assay: A laboratory study
by: Hamid Reza Momeni, et al.
Published: (2020)

COMPARATIVE-EVALUATION-OF-TWO-VIABILITY ASSAYS ON BIODEGRADABLE POLYMER FOAMS FOR POTENTIAL BONE REGENERATION
by: Ana Maria Holicov, et al.
Published: (2014)

Determining the viability of Schistosoma mansoni cercariae using fluorescence assays: An application for water treatment.
by: Laura Braun, et al.
Published: (2020)

Multimetal organic frameworks as drug carriers: aceclofenac as a drug candidate
by: Al Haydar M, et al.
Published: (2018)

Current pipelines for neglected diseases.
by: Paolo di Procolo, et al.
Published: (2014)

Some Candidate Drugs for Pharmacotherapy of Alzheimer's Disease
by: Barbara Miziak, et al.
Published: (2021)

Potential Rx-to-OTC Switch Drug Candidates
by: Victor Phan, et al.
Published: (2016)

Pharmacomodulations around an anti-Alzheimer drug-candidate
by: Sylvain Marc, et al.
Published: (2022)